89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details


臨床試験数 : 39 薬物数 : 46 - (DrugBank : 20) / 標的遺伝子数 : 27 - 標的パスウェイ数 : 137

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00989742
(ClinicalTrials.gov)
July 20092/10/2009Doxycycline In Lymphangioleiomyomatosis (LAM)A Randomised, Double Blind, Placebo Controlled Trial of Doxycycline in Lymphangioleiomyomatosis.Lymphangioleiomyomatosis;Tuberous SclerosisDrug: Doxycycline;Drug: PlaceboUniversity of NottinghamNULLCompleted18 YearsN/AFemale24Phase 4United Kingdom
2EUCTR2007-003745-32-GB
(EUCTR)
12/12/200826/11/2010A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAMA randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAM Lymphangioleiomyomatosis
MedDRA version: 9.1;Level: LLT;Classification code 10049459;Term: Lymphangioleiomyomatosis
MedDRA version: 9.1;Level: PT;Term: Lymphangioleiomyomatosis
Trade Name: Doxycycline 100 mg Capsules
INN or Proposed INN: doxycycline
University of NottinghamNULLNot RecruitingFemale: yes
Male: no
United Kingdom